TNGX
$22.04-2.91%
Tango Therapeutics Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.007%US Stock Market 0.006%Russell 3000 0.005%
Tango Therapeutics Inc. total returns by year (including dividends)
As of market close, Oct 16, 2026
Tango Therapeutics Inc. total returns by year (2021–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $8.86 | $22.04 | 0.0% | +148.8% | |
| 2025 | $3.09 | $8.86 | 0.0% | +186.7% | |
| 2024 | $9.90 | $3.09 | 0.0% | -68.8% | |
| 2023 | $7.25 | $9.90 | 0.0% | +36.6% | |
| 2022 | $10.94 | $7.25 | 0.0% | -33.7% | |
| 2021 | $11.44 | $10.94 | 0.0% | -4.4% |
- Annualized
- +13.3%
- 2021–2026
- Average year
- +23.3%
- 5 full years
- Best year
- +186.7%
- 2025
- Worst year
- -68.8%
- 2024
- Positive years
- 2/5
- 40% up
Annualized (CAGR)
+13.3%
2021–2026
Average year
+23.3%
5 full years
Best year
+186.7%
2025
Worst year
-68.8%
2024
Positive years
2/5
40% up
Total return by period#
Annual
-100%0%100%
2021-4.4%'21
2022-34%'22
2023+37%'23
2024-69%'24
2025+187%'25
2026+149%'26
Methodology#
Total returns, dividends reinvested, measured on TNGX. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Tango Therapeutics Inc.'s average annual return?
- Since 2021, Tango Therapeutics Inc. (TNGX) has returned about 13.3% a year (the compound annual growth rate) and an average calendar-year return of 23.3%.
- What were Tango Therapeutics Inc.'s best and worst years?
- Over 2021–2026, the best year was 2025 (+186.7%) and the worst was 2024 (-68.8%).
- How often is Tango Therapeutics Inc. up in a year?
- 2 of the 5 full years since 2021 were positive — about 40% of the time.
More on Tango Therapeutics Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100